Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,4535,510,1.58 [1.26-1.99],8.625699243618164e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",4430,500,1.55 [1.35-1.77],1.07763125097586e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,4466,505,2.65 [2.08-3.38],4.175595606382386e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,4484,500,1.87 [1.61-2.18],3.866508244498319e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3888,421,2.24 [1.75-2.88],1.807490692784244e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,4466,505,2.04 [1.67-2.49],1.9934749581776344e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,4527,505,2.29 [1.80-2.91],1.4967703344007246e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,4547,512,2.29 [1.87-2.79],5.811896793246971e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,4485,502,1.22 [1.14-1.31],4.1206163555394965e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,4508,505,0.50 [0.38-0.66],7.636626219034065e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,4430,500,0.84 [0.77-0.91],8.59458396423247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,4543,508,1.92 [1.44-2.55],7.594856763799288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,3917,422,0.36 [0.24-0.54],6.375328105859507e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,4457,503,0.69 [0.61-0.78],7.589734572627236e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,4347,490,1.29 [1.20-1.39],1.0554369415067675e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,4527,505,1.74 [1.46-2.08],8.645471242699213e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,4564,512,2.04 [1.43-2.90],7.542936563976144e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,4538,507,3.93 [2.79-5.55],6.639972068988979e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,4485,502,1.78 [1.29-2.45],0.0003948944035083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,4507,503,1.71 [1.39-2.12],6.787046157194084e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,4520,504,1.76 [1.49-2.08],3.812928734560372e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,4377,495,1.16 [1.07-1.26],0.0004586517044487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,4363,492,1.74 [1.44-2.12],1.8426354223669657e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,4526,507,3.18 [2.51-4.03],1.476538346849945e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,3921,425,1.36 [1.15-1.62],0.0003880786920865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,3917,422,2.44 [1.98-3.01],9.436809156002174e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,3908,422,0.53 [0.42-0.68],2.579870963599835e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,3917,422,0.69 [0.57-0.82],5.0650774462712566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,4485,502,1.95 [1.69-2.25],4.006599565752704e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,4526,507,1.66 [1.36-2.01],4.4405689552816843e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,4473,505,1.69 [1.34-2.12],7.355699854718005e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,3921,425,2.03 [1.49-2.76],6.93771429645111e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,3888,421,2.05 [1.62-2.61],4.094144017855636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,4526,507,1.68 [1.29-2.19],0.0001169242695576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,3917,422,2.16 [1.68-2.79],2.2602738796106147e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3805,414,3.01 [2.35-3.86],2.204045757886936e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",4527,505,2.22 [1.73-2.85],3.3486158188392016e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,4377,493,1.70 [1.38-2.09],6.035494098470809e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,4525,508,1.73 [1.27-2.35],0.0004606210099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,4473,505,0.52 [0.42-0.64],1.0969129808396524e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",4504,507,1.61 [1.31-1.98],6.62337665571866e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,3920,425,0.75 [0.69-0.82],4.1685342133466326e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,3838,411,1.79 [1.34-2.41],0.0001017536500837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,3838,411,2.44 [1.72-3.46],6.652051903160031e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,4430,500,2.68 [1.94-3.68],1.6202492301727275e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,4548,506,2.07 [1.48-2.89],2.3124021782372443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,4527,505,2.67 [2.15-3.32],6.737248650763448e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,4504,507,1.42 [1.15-1.74],0.0008633663044344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,4526,507,1.39 [1.20-1.61],1.0503327507829786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,4523,505,2.88 [1.94-4.28],1.643092414874641e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,3818,416,2.55 [1.99-3.27],1.8708724293512889e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,4485,502,2.36 [2.00-2.78],1.5618746074635575e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,4543,508,1.50 [1.24-1.83],3.9069315573002125e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,4564,512,1.67 [1.25-2.23],0.000537152681215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,4543,508,1.54 [1.35-1.75],5.14188754580504e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,4377,495,1.84 [1.47-2.31],1.4429436820125537e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,4464,504,1.31 [1.17-1.45],8.955442632816388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,4506,503,1.18 [1.08-1.29],0.0003849838687405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,4556,506,1.92 [1.57-2.35],1.8205303227384843e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,4507,503,1.45 [1.21-1.73],6.692341603718205e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,4564,512,1.74 [1.50-2.02],3.3870085850830465e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,4527,505,1.33 [1.16-1.52],3.0025179114843926e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,4556,506,1.73 [1.47-2.02],2.1138696505197542e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,4550,512,1.46 [1.20-1.78],0.0001880332031311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,4543,508,1.67 [1.40-1.99],1.1745828239925576e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,4525,508,1.54 [1.28-1.86],6.547597048314057e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,4525,508,1.67 [1.34-2.08],5.871400628612227e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,4439,496,1.81 [1.51-2.16],5.776806521272817e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,4556,506,1.73 [1.50-2.00],5.3811512163470993e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,4526,507,1.35 [1.14-1.59],0.0005512241829454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,4525,508,1.54 [1.33-1.77],3.4403500972661404e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,4504,507,1.79 [1.40-2.29],3.837008228450434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,4413,497,1.68 [1.39-2.03],7.02071588545721e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,4513,505,2.32 [2.00-2.69],6.081150152007033e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,4473,505,1.48 [1.21-1.81],0.000151415064515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,4504,504,2.54 [2.10-3.07],3.464491832521821e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,4377,493,1.65 [1.36-2.00],4.867074562284329e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,4541,507,1.68 [1.37-2.06],6.393880829113209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,4527,505,1.52 [1.28-1.80],2.024029034128679e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,4525,508,1.42 [1.17-1.72],0.0003096370004471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,4485,502,2.09 [1.72-2.55],3.0575661802732896e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,4498,506,1.55 [1.23-1.94],0.000148415801594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,4510,504,1.29 [1.11-1.48],0.0005762843771272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,4488,499,2.00 [1.55-2.56],6.1756241665878e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,4520,504,1.98 [1.54-2.55],1.0618391101384449e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,4538,507,1.81 [1.50-2.19],1.0881307761197932e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,4350,485,1.93 [1.50-2.50],4.608917416540668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,4336,488,2.20 [1.68-2.88],8.840452420024645e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,3781,417,1.46 [1.19-1.78],0.0002345044868152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,4541,507,2.15 [1.75-2.63],1.9083980161996437e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,4556,506,1.70 [1.46-1.98],6.6196307662510615e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,3900,420,1.65 [1.30-2.09],3.4942319505454495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,4504,507,1.58 [1.29-1.94],1.0331761741673992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,4363,484,1.52 [1.20-1.92],0.0004918434672565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,4525,508,2.33 [1.62-3.35],4.777984980340456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,4352,489,2.01 [1.77-2.27],5.5722728840699175e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,4532,506,1.20 [1.09-1.31],0.0001943778535818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,4508,505,1.51 [1.37-1.66],1.0734784285503577e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,4541,507,1.54 [1.27-1.87],9.205008190890953e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,4485,502,1.35 [1.13-1.61],0.0008664378485013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,4504,507,1.16 [1.07-1.26],0.0005608512208388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,4331,490,1.27 [1.13-1.43],7.931904060586732e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,4485,502,1.29 [1.14-1.47],9.600591757254056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,4525,508,1.32 [1.19-1.47],2.808878330698062e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,4508,505,1.73 [1.48-2.03],8.27868722196763e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,3838,411,0.50 [0.42-0.59],1.6258716499302611e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3892,422,1.83 [1.51-2.22],6.354932714368248e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,3920,425,1.18 [1.09-1.27],1.7514747195452346e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,4522,505,1.56 [1.33-1.84],9.707960000164033e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,4404,493,1.22 [1.12-1.33],6.1380252516873865e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,4520,504,1.76 [1.41-2.20],5.799185851565476e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,3920,425,1.61 [1.36-1.91],3.0326292424511417e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,4539,506,2.23 [1.83-2.72],1.835953677140045e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,3920,425,1.42 [1.23-1.63],9.232326373731764e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",4491,502,1.36 [1.21-1.54],8.619416704959524e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,4525,508,1.86 [1.50-2.31],2.0047335748314604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,4430,500,1.61 [1.31-1.98],7.143036824894876e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,3821,409,0.31 [0.21-0.47],1.3787805749321233e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,4499,505,1.69 [1.34-2.14],1.305962121572752e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,4556,506,1.42 [1.22-1.66],6.867846170843786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,4543,508,2.04 [1.49-2.80],1.0150433568893466e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,4564,512,1.66 [1.26-2.17],0.0002681617215145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,4543,508,1.39 [1.18-1.64],8.77001760900234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,4524,509,2.78 [2.07-3.71],6.129065518396936e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,4564,512,0.53 [0.39-0.73],9.928064950505363e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,4508,505,1.77 [1.52-2.06],3.071919659951779e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,4564,512,1.82 [1.52-2.18],5.1244183262926654e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,4504,504,2.28 [1.78-2.91],4.4485203903141845e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,4529,506,1.52 [1.38-1.67],8.247087928357923e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,4514,501,1.45 [1.18-1.77],0.0003449054352517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,3900,420,1.75 [1.25-2.43],0.0009781907067494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,4449,496,0.58 [0.48-0.70],1.3715843160520893e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,4504,504,1.59 [1.21-2.08],0.0008202501046755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,4527,505,2.00 [1.41-2.85],0.0001013149832283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,4473,505,1.47 [1.20-1.79],0.0001484247375153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,3882,420,0.41 [0.30-0.57],8.573460906527608e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,4473,505,1.34 [1.15-1.56],0.0001446965127794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,4527,505,1.89 [1.46-2.44],1.4731581226714914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,4511,507,1.94 [1.55-2.43],7.016283348045964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,3920,425,1.79 [1.36-2.37],3.637541579192034e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,3838,411,1.47 [1.25-1.72],2.6618307440987685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,4508,505,1.85 [1.38-2.49],4.041189290985535e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,4556,506,1.73 [1.37-2.18],3.1319264479595167e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,3542,376,2.51 [1.69-3.72],4.543670430132609e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,4513,505,1.72 [1.38-2.15],1.380118412637482e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,3819,418,1.30 [1.14-1.49],0.0001386462437033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,4473,505,1.71 [1.39-2.10],2.806122761600116e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,4560,512,1.73 [1.27-2.34],0.0004381224627951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,4527,505,1.29 [1.16-1.44],2.046119987734172e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,3920,425,0.54 [0.38-0.77],0.0007228390429912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4513,505,2.43 [1.99-2.98],4.9365646027735575e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,4430,500,2.90 [2.16-3.89],1.3779493039818277e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,4513,505,0.79 [0.69-0.91],0.0008032503850982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,4541,507,1.69 [1.25-2.30],0.0007629372251173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,4467,504,1.83 [1.59-2.11],1.132240710122497e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,4513,505,2.77 [2.24-3.42],4.017750130433832e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,3805,414,0.61 [0.53-0.69],1.2918386758869294e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,4485,502,1.99 [1.64-2.42],4.166680922451238e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,4471,495,2.20 [1.89-2.55],7.231243929248674e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,4525,508,2.30 [1.82-2.91],3.340638022935e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,4468,501,0.69 [0.59-0.80],1.683344825249649e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,4485,502,1.97 [1.47-2.65],6.069431464272862e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,4535,508,1.85 [1.45-2.35],5.384678282720561e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,4543,508,2.18 [1.88-2.54],1.9237387336235552e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,4430,500,1.60 [1.30-1.96],8.472131459545562e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,3805,414,1.90 [1.41-2.56],2.3631669140302224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,3888,421,2.05 [1.57-2.68],1.792500203342863e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4522,507,1.80 [1.45-2.25],1.4457791921251896e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,4520,507,2.61 [2.12-3.22],2.456100830052999e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,4466,505,3.03 [2.52-3.63],1.5297479477479342e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,3805,414,0.77 [0.66-0.89],0.0006280805579542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,3805,414,1.64 [1.27-2.11],0.0001149491233156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,4340,487,2.58 [2.16-3.08],1.2163314692293734e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,4564,512,2.84 [2.23-3.61],3.04828522902083e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,4464,504,1.53 [1.23-1.91],0.0001288939974957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,4504,507,1.21 [1.11-1.33],2.052719873346776e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,4537,507,1.52 [1.22-1.89],0.0001761734561175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,4513,505,2.23 [1.75-2.85],1.2161264375562772e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,4564,512,1.72 [1.39-2.13],8.013112420306046e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,3868,418,1.77 [1.30-2.40],0.0002677448897515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,4520,504,1.28 [1.12-1.47],0.0003989995087918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,4514,506,1.70 [1.32-2.20],4.190146341944468e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",4504,504,1.24 [1.15-1.34],2.2765698545921026e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",4508,505,1.18 [1.08-1.30],0.0002158620643488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",3900,420,1.49 [1.28-1.72],9.491147319397285e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",4564,512,1.62 [1.44-1.83],1.5419843952043805e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,4485,502,2.11 [1.72-2.60],1.5572082902726662e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,4506,503,3.04 [2.47-3.75],1.3446966456494204e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,3888,421,1.44 [1.29-1.60],1.4586226614419378e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,4554,512,1.50 [1.26-1.79],5.31733517581212e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,4525,508,1.27 [1.11-1.46],0.0007163379367876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,4491,501,0.69 [0.57-0.82],3.718061764022059e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,4531,507,1.24 [1.11-1.39],0.0002184505943539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,4402,494,2.02 [1.65-2.46],4.749609933975656e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,4513,505,0.56 [0.46-0.69],1.4847280819493245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,3920,425,0.61 [0.51-0.74],1.1251166687835752e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,3892,422,0.58 [0.45-0.74],1.6145433277513015e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,3921,425,1.43 [1.25-1.64],2.524607182293473e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,3917,422,0.44 [0.31-0.62],2.228866553538071e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,4492,501,1.74 [1.36-2.21],6.954838540221249e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,3805,414,1.40 [1.18-1.65],7.772064688411056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,3805,414,2.35 [1.60-3.46],1.4718328519389655e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,4501,501,1.85 [1.52-2.26],1.234824986491009e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,4513,505,0.68 [0.55-0.84],0.0004171011256613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,4402,494,1.59 [1.34-1.88],9.087779988805953e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,4485,502,1.89 [1.30-2.75],0.0008203869372357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,4377,493,1.23 [1.16-1.31],2.290042671806098e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4485,502,1.67 [1.35-2.08],3.338093193958408e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,4564,512,2.13 [1.93-2.36],1.043757321828054e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,4535,508,2.78 [2.22-3.49],5.5334323592025875e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,4461,502,1.69 [1.30-2.19],9.121010581615924e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,4473,505,2.41 [1.82-3.19],7.152306197043472e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,4506,503,1.09 [1.04-1.13],0.0002442728404636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,3838,411,0.42 [0.31-0.58],5.779095972160268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,3805,414,1.40 [1.20-1.65],3.3556732164767354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,3892,422,1.65 [1.26-2.16],0.0002432018877207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,3835,415,1.60 [1.30-1.98],1.0713192724061925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",3920,425,0.66 [0.54-0.81],7.054753040735657e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,4375,497,1.14 [1.06-1.23],0.0007447710081521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,4485,502,0.90 [0.84-0.95],0.0003491915003091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,4543,508,1.60 [1.24-2.05],0.0002355370359948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,4399,491,2.57 [1.98-3.34],1.7815547136563326e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,4430,500,1.36 [1.21-1.53],1.4840489011964e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,4503,507,3.10 [2.31-4.14],2.4494901578757452e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,4501,505,0.85 [0.78-0.92],0.0001738658845575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,4504,507,1.84 [1.53-2.20],5.013831678426596e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,4538,507,1.69 [1.55-1.84],3.5995623656662625e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,4525,508,1.86 [1.53-2.27],8.431150824875131e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,3900,420,3.35 [2.38-4.71],3.9099593110683705e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4504,507,1.96 [1.59-2.43],5.685846191422493e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,4543,508,1.50 [1.26-1.79],6.098826428066079e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4482,499,1.73 [1.37-2.19],4.499659801940284e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,4476,499,1.77 [1.30-2.41],0.0002992640292038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,4564,512,1.86 [1.36-2.53],8.398915646244582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,4564,512,1.63 [1.28-2.08],6.9376377787064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,4564,512,1.63 [1.25-2.14],0.0003133596843836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,4527,505,2.12 [1.52-2.94],7.69904975586534e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,4485,502,2.34 [1.73-3.18],4.0485097562654343e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,4559,511,1.13 [1.07-1.21],8.616776742082872e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,4557,512,1.43 [1.28-1.59],1.2122942700716575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,4526,507,0.66 [0.55-0.80],9.254341144300397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,4469,500,1.75 [1.54-1.99],5.464746319276142e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,4500,502,1.66 [1.36-2.03],8.57247440345699e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,4564,512,1.56 [1.29-1.90],6.895490634548091e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,4508,505,1.70 [1.37-2.10],1.3546580193128283e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,4527,505,1.85 [1.46-2.34],2.9994320820195813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,4402,494,1.43 [1.17-1.75],0.0005872355728584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,4504,507,1.70 [1.39-2.08],1.891512656280021e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,4402,494,1.59 [1.28-1.96],1.947532623947784e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,4402,494,1.37 [1.26-1.49],1.804797305281615e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,4454,502,1.32 [1.15-1.53],0.0001210540728949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,4526,507,2.03 [1.65-2.52],5.2801736510654376e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,4556,506,1.68 [1.36-2.07],1.10536637103247e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,4409,495,1.21 [1.10-1.32],9.308234404543556e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,4520,507,4.50 [3.48-5.84],5.354363676467239e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,4554,512,1.59 [1.34-1.88],1.03602611067133e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,4483,502,1.67 [1.41-1.98],4.298169039583157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,4504,507,1.69 [1.41-2.04],3.3618119151398985e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,4508,505,2.46 [1.62-3.73],2.5502692358295025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,3890,418,1.40 [1.20-1.63],1.373697725555158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,4525,508,1.60 [1.28-1.99],3.55096973413972e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,4495,507,1.87 [1.47-2.37],2.910280392513369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,4402,494,2.11 [1.64-2.71],6.7571357228429086e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,4543,508,1.45 [1.24-1.69],2.634209939574101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4526,507,1.90 [1.55-2.32],4.4725694043020607e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,4541,507,2.77 [2.20-3.49],4.9177923030564484e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,4508,505,1.40 [1.16-1.70],0.0005269033963896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,4377,495,1.26 [1.14-1.40],8.065406298128545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,4463,500,1.87 [1.53-2.30],2.006275682963988e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,4543,508,1.61 [1.47-1.78],2.142689974193454e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,3734,400,0.64 [0.50-0.82],0.0005055034148296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,4556,506,2.34 [1.98-2.78],8.487844156791457e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,4556,506,1.50 [1.28-1.77],8.472880795277155e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,3892,422,1.44 [1.17-1.77],0.0005629403421516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",4495,506,1.56 [1.42-1.72],3.5565298038371755e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,4556,506,0.76 [0.66-0.89],0.0005915935265173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,4485,502,1.65 [1.43-1.90],1.1034390489447824e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4504,504,1.65 [1.45-1.89],2.145676153822958e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,4464,504,2.41 [2.05-2.82],2.7187166302642548e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,3905,425,1.36 [1.22-1.50],8.747909274334868e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,4381,496,1.42 [1.19-1.69],8.135413021264348e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,4508,505,1.93 [1.53-2.42],1.6210910868691106e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,4512,506,1.90 [1.48-2.44],5.225280912938591e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,4504,504,1.78 [1.59-2.00],1.227252369691705e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,4510,504,1.50 [1.19-1.90],0.0006057457637789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,4504,507,3.89 [3.03-5.00],2.785704626377311e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,3905,425,1.83 [1.48-2.26],2.945881113785292e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,4362,495,1.44 [1.28-1.61],4.761257566293098e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4530,507,1.53 [1.24-1.88],8.466429754808486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,4508,505,1.58 [1.30-1.91],2.966150567847184e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,4564,512,2.04 [1.66-2.52],2.1115636539182947e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,4484,502,1.79 [1.43-2.24],3.2266523438676497e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,4479,499,1.39 [1.18-1.65],0.0001293908340109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,4449,494,1.79 [1.41-2.29],2.607387749984936e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,4467,501,1.43 [1.16-1.78],0.000921666607209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,4377,493,1.21 [1.09-1.34],0.0003578027297761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,3900,420,1.82 [1.45-2.29],2.3105322566459065e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,4526,507,1.80 [1.48-2.20],6.432930893357683e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,4501,504,1.52 [1.34-1.72],6.347291936675922e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,4504,504,0.48 [0.37-0.62],3.666983344087192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,3838,411,1.80 [1.37-2.35],1.8138807575106903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,4525,508,1.36 [1.17-1.58],4.802465669906767e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,4363,489,1.23 [1.12-1.34],8.190649172884917e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,4499,503,1.38 [1.22-1.56],2.441307784431804e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,4509,504,1.46 [1.28-1.66],2.1344867624592322e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,4525,508,1.33 [1.15-1.52],6.724916195411308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,4425,500,1.70 [1.45-1.99],9.7574041316815e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,3921,425,1.79 [1.33-2.41],0.0001379004250427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,4541,507,1.46 [1.24-1.73],5.117628448658139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,4377,495,1.76 [1.58-1.96],2.600620738714185e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,4513,505,2.21 [1.72-2.83],4.5975860614625004e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,4541,507,0.53 [0.44-0.64],9.117089176004392e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,4500,506,1.94 [1.61-2.33],3.736153210920101e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3888,421,2.02 [1.59-2.57],1.2127597417206082e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,4543,508,2.17 [1.69-2.77],9.639633541705496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,4506,503,2.34 [1.90-2.87],9.220943526712165e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,4513,505,1.95 [1.66-2.29],5.643307591468919e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,4363,493,2.07 [1.83-2.35],6.7197870989077e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,4513,505,0.60 [0.51-0.71],3.7428986199279856e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,4556,506,2.80 [2.24-3.51],2.269518380250945e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,4564,512,4.04 [2.57-6.35],1.303600401204157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,3866,417,2.14 [1.65-2.78],9.8701313839607e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,4508,505,1.65 [1.36-1.98],1.7751195575686973e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,4543,508,1.30 [1.16-1.47],1.0259092065320356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,4508,505,2.01 [1.61-2.52],1.0864604283733647e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,4530,508,2.15 [1.65-2.80],1.1272697353450941e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,4508,505,1.14 [1.07-1.21],1.689900554688748e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,4525,508,1.65 [1.41-1.93],6.184750330518732e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,4527,505,0.69 [0.59-0.81],6.805281014949253e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,4485,502,0.81 [0.72-0.90],0.0001396444320683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,4530,508,1.95 [1.36-2.80],0.0002940196365971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,3892,422,1.52 [1.24-1.87],7.161508044192238e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,4536,506,1.71 [1.24-2.36],0.000999280881239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,4508,505,1.44 [1.20-1.73],9.152451097910845e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,3888,421,1.69 [1.39-2.06],2.1580778074490776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,4537,506,1.36 [1.16-1.59],0.0001904030310933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,4485,502,2.35 [1.89-2.90],5.615530470783089e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,4508,505,1.97 [1.54-2.52],5.350100915017122e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,4564,512,1.86 [1.33-2.59],0.000265318504538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,4556,506,2.02 [1.57-2.61],5.382955372563484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,3888,421,1.37 [1.15-1.63],0.0003777758281711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,4456,504,1.25 [1.11-1.41],0.0002502209830611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,4461,498,1.88 [1.57-2.25],9.746359108419004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4525,508,2.84 [2.32-3.48],6.487190743065575e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,4525,508,1.72 [1.43-2.06],8.274059701168134e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,4508,505,1.39 [1.21-1.61],6.0889542135700365e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,3900,420,2.72 [1.97-3.76],1.4024887205656992e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,4473,505,1.49 [1.31-1.70],1.5055743832306547e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,4525,508,0.45 [0.37-0.54],4.6822382006596425e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,4554,512,0.73 [0.64-0.84],8.832287169210128e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,4485,504,2.17 [1.68-2.80],2.150480793625498e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",3892,422,0.72 [0.61-0.84],4.781962372096214e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,4543,510,3.76 [3.01-4.70],3.229610572911468e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,3792,418,1.60 [1.37-1.86],1.328215158992462e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3905,425,1.53 [1.27-1.84],5.628962498108068e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,4490,497,1.20 [1.12-1.29],2.971504100515832e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,3920,425,1.94 [1.53-2.47],7.118414427748846e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,4540,510,1.69 [1.37-2.08],6.347232093272087e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,4504,504,1.84 [1.34-2.53],0.0001823060824936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,4499,505,1.62 [1.35-1.95],2.304393448243707e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,3892,422,0.65 [0.52-0.81],0.0001125911837529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,4493,502,1.77 [1.49-2.11],1.3583660445685474e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,3894,423,2.24 [1.63-3.08],6.620769734039533e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,4473,505,1.28 [1.19-1.38],7.5623859778227e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,4477,500,1.88 [1.55-2.29],1.2100887552691993e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,4377,495,1.59 [1.30-1.96],7.452160478520317e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,3900,420,1.77 [1.32-2.37],0.0001523003602007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,3888,421,1.38 [1.16-1.64],0.0002133670276866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4458,503,1.56 [1.27-1.92],2.4482351032316645e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,4504,507,1.35 [1.13-1.60],0.0008022189662269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,3783,414,1.32 [1.22-1.42],9.963560126947985e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,4521,510,1.96 [1.48-2.60],2.944905528031644e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,4504,507,0.69 [0.59-0.82],1.5082632384991465e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,4377,493,1.53 [1.25-1.88],3.358393415766616e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,3905,425,1.61 [1.35-1.92],7.145722483849604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,4409,502,0.74 [0.66-0.83],7.610515367844351e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,4485,502,1.26 [1.15-1.38],6.171283725906262e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,4485,500,2.03 [1.82-2.27],6.19056246806358e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,4564,512,1.66 [1.49-1.85],1.092210574362691e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,4564,512,1.49 [1.35-1.65],3.1192906799112145e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,4513,504,2.06 [1.83-2.31],3.91972829157956e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,4525,508,1.73 [1.37-2.18],4.300965812384002e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,4508,505,1.49 [1.39-1.60],4.268071400355856e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,4541,507,1.61 [1.28-2.03],4.313759512422086e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,4541,507,1.63 [1.27-2.09],0.0001414424897341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,3921,425,2.14 [1.57-2.91],1.3816299112267611e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,3780,411,1.76 [1.30-2.40],0.0002894448963081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,3888,420,1.68 [1.40-2.00],9.707655755930604e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,4550,512,2.35 [1.93-2.87],3.200250181263067e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,3805,414,2.26 [1.75-2.93],6.10148933622655e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4508,505,1.57 [1.26-1.96],5.807090068755618e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,4543,508,1.60 [1.26-2.04],0.0001022174126879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,4543,508,1.92 [1.55-2.39],3.910446269944272e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,3905,425,0.69 [0.57-0.85],0.0003321375794786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,4430,500,1.28 [1.15-1.43],6.835719993297276e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,4541,507,2.91 [2.35-3.60],1.322999037789524e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,4382,499,2.13 [1.77-2.57],8.736895111929734e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,4541,507,2.27 [1.81-2.85],9.809993808911226e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,4525,507,2.30 [1.89-2.81],2.1969108450449423e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,4513,504,1.31 [1.13-1.51],0.0002354495525966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,4402,494,1.87 [1.64-2.13],1.756517951203143e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,3819,418,1.39 [1.16-1.67],0.0003251297122434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,3805,414,1.69 [1.40-2.03],2.8814188384409323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,4554,512,2.02 [1.63-2.52],2.5630171281575703e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,3884,422,1.53 [1.21-1.93],0.000334032610848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,4513,505,1.72 [1.33-2.23],3.5716542068853524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,3920,425,1.88 [1.44-2.46],4.152356850898194e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,4527,505,1.49 [1.25-1.78],8.232613337455621e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,4504,507,1.70 [1.38-2.08],3.609904911908648e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,4543,508,2.34 [1.86-2.93],2.199535183314624e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,4515,508,1.30 [1.13-1.51],0.0004004879462077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,4494,502,1.65 [1.41-1.93],3.3387999888311953e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,4402,494,1.35 [1.18-1.54],1.128123910615766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,4504,507,1.31 [1.15-1.49],4.145322613482805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,4377,493,1.29 [1.11-1.49],0.0008183730564915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,4377,495,1.41 [1.18-1.68],0.0001169491106283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,4543,508,1.54 [1.27-1.86],7.670409875629017e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,4430,500,1.80 [1.50-2.17],4.5473284770048605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,4527,505,1.63 [1.36-1.94],5.431770979635104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,4473,505,1.36 [1.22-1.53],1.0841190429501909e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",3805,414,1.66 [1.30-2.12],5.545709197778318e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,4377,493,1.60 [1.31-1.94],2.243674009727004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,4521,506,0.82 [0.74-0.90],9.120782891895145e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,4525,508,2.04 [1.81-2.30],9.717220471588138e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,4504,507,1.74 [1.58-1.91],3.0111637411017293e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,4527,505,1.66 [1.38-2.00],6.086104952687872e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,4473,505,0.43 [0.33-0.57],4.348622199195594e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,4513,504,2.08 [1.70-2.53],4.40324471016184e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,4490,501,1.71 [1.40-2.09],2.0075805551377968e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4485,502,1.51 [1.31-1.75],1.0434984308205544e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,4525,508,1.68 [1.31-2.16],3.680247388058656e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,3988,444,2.18 [1.66-2.86],1.585829870750883e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,4485,502,1.63 [1.36-1.94],7.574599313027599e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,4470,504,0.87 [0.81-0.94],0.0002851249114445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,4557,512,2.14 [1.73-2.65],3.190759203393278e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,4504,507,1.42 [1.31-1.53],7.321905036027103e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,4520,504,1.68 [1.51-1.87],2.2718504142674587e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,4489,506,1.74 [1.55-1.96],1.4605909140166238e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,4504,507,1.42 [1.23-1.65],2.661938029477163e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,4488,501,0.56 [0.43-0.74],4.023886952169745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,4513,505,1.94 [1.65-2.28],1.3906936892893381e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,3921,425,1.91 [1.40-2.62],5.084047224307209e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,4508,505,1.76 [1.40-2.21],1.499313995357634e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,4454,501,1.61 [1.27-2.04],7.244635894349461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,4500,503,1.90 [1.36-2.64],0.000155521091677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,4485,502,1.34 [1.23-1.46],2.4812038241106928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,4426,499,1.35 [1.14-1.59],0.0003729787794915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4473,505,2.04 [1.73-2.41],4.6848384688610717e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4473,505,1.41 [1.28-1.55],1.112812324498066e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4556,506,2.12 [1.82-2.47],2.8140185330705585e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4504,504,1.60 [1.28-2.01],4.561593383818789e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4513,505,2.03 [1.69-2.43],2.5977764089832882e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4513,504,1.63 [1.35-1.98],5.018879950809479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,4402,494,1.36 [1.15-1.62],0.0004669468377244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4513,504,2.37 [1.97-2.87],2.438314147062773e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4543,508,1.78 [1.49-2.13],3.463281593083864e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4525,508,2.69 [2.20-3.28],1.8955071936035408e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4525,508,1.50 [1.33-1.69],4.414203906741656e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4541,507,1.81 [1.40-2.34],5.188993628330136e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4548,506,2.01 [1.70-2.38],4.447972855162343e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4473,505,1.32 [1.16-1.50],2.6895897114396773e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4541,507,1.37 [1.17-1.61],7.722051709905206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4473,505,1.67 [1.45-1.93],2.813539723580302e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,4527,505,2.49 [1.92-3.23],7.228575805794594e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,3900,420,0.50 [0.36-0.69],3.302167430342716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,4508,505,0.84 [0.76-0.92],0.0004589957559846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,4473,505,1.65 [1.38-1.97],3.7715395196182056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,4547,507,0.72 [0.63-0.82],7.613425060427186e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,3892,422,1.46 [1.19-1.81],0.0003526354589815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,4439,494,2.04 [1.57-2.65],7.582297098158659e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,4523,505,2.03 [1.59-2.60],1.5064164320897864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,4548,505,1.82 [1.50-2.21],1.2241480422609604e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,3890,418,1.46 [1.31-1.64],3.442018448075152e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,4518,507,2.01 [1.72-2.35],3.448868211009339e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,3892,422,0.64 [0.51-0.81],0.0001479510112768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,4430,500,1.22 [1.09-1.38],0.0009108954653549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,4457,504,1.50 [1.25-1.79],1.5166239783904406e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,4284,468,1.92 [1.65-2.22],9.984337813938409e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,4543,508,0.60 [0.48-0.76],1.0158257068351511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,4402,494,1.98 [1.64-2.38],7.075971291249404e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,4543,508,1.27 [1.13-1.43],9.606998391732506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,4540,511,1.85 [1.52-2.25],1.0048447987570779e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,3892,422,2.14 [1.61-2.84],1.2809013122506346e-07
